Display options
Cite
Turcot V, Lu Y, Highland HM, et al. Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. Nat Genet. 2017;50(1):26-41doi: 10.1038/s41588-017-0011-x.
Turcot, V., Lu, Y., Highland, H. M., Schurmann, C., Justice, A. E., Fine, R. S., Bradfield, J. P., Esko, T., Giri, A., Graff, M., Guo, X., Hendricks, A. E., Karaderi, T., Lempradl, A., Locke, A. E., Mahajan, A., Marouli, E., Sivapalaratnam, S., Young, K. L., Alfred, T., Feitosa, M. F., Masca, N. G. D., Manning, A. K., Medina-Gomez, C., Mudgal, P., Ng, M. C. Y., Reiner, A. P., Vedantam, S., Willems, S. M., Winkler, T. W., Abecasis, G., Aben, K. K., Alam, D. S., Alharthi, S. E., Allison, M., Amouyel, P., Asselbergs, F. W., Auer, P. L., Balkau, B., Bang, L. E., Barroso, I., Bastarache, L., Benn, M., Bergmann, S., Bielak, L. F., Blüher, M., Boehnke, M., Boeing, H., Boerwinkle, E., Böger, C. A., Bork-Jensen, J., Bots, M. L., Bottinger, E. P., Bowden, D. W., Brandslund, I., Breen, G., Brilliant, M. H., Broer, L., Brumat, M., Burt, A. A., Butterworth, A. S., Campbell, P. T., Cappellani, S., Carey, D. J., Catamo, E., Caulfield, M. J., Chambers, J. C., Chasman, D. I., Chen, Y. I., Chowdhury, R., Christensen, C., Chu, A. Y., Cocca, M., Collins, F. S., Cook, J. P., Corley, J., Corominas Galbany, J., Cox, A. J., Crosslin, D. S., Cuellar-Partida, G., D'Eustacchio, A., Danesh, J., Davies, G., Bakker, P. I. W., Groot, M. C. H., Mutsert, R., Deary, I. J., Dedoussis, G., Demerath, E. W., Heijer, M., Hollander, A. I., Ruijter, H. M., Dennis, J. G., Denny, J. C., Di Angelantonio, E., Drenos, F., Du, M., Dubé, M. P., Dunning, A. M., Easton, D. F., Edwards, T. L., Ellinghaus, D., Ellinor, P. T., Elliott, P., Evangelou, E., Farmaki, A. E., Farooqi, I. S., Faul, J. D., Fauser, S., Feng, S., Ferrannini, E., Ferrieres, J., Florez, J. C., Ford, I., Fornage, M., Franco, O. H., Franke, A., Franks, P. W., Friedrich, N., Frikke-Schmidt, R., Galesloot, T. E., Gan, W., Gandin, I., Gasparini, P., Gibson, J., Giedraitis, V., Gjesing, A. P., Gordon-Larsen, P., Gorski, M., Grabe, H. J., Grant, S. F. A., Grarup, N., Griffiths, H. L., Grove, M. L., Gudnason, V., Gustafsson, S., Haessler, J., Hakonarson, H., Hammerschlag, A. R., Hansen, T., Harris, K. M., Harris, T. B., Hattersley, A. T., Have, C. T., Hayward, C., He, L., Heard-Costa, N. L., Heath, A. C., Heid, I. M., Helgeland, �. �., Hernesniemi, J., Hewitt, A. W., Holmen, O. L., Hovingh, G. K., Howson, J. M. M., Hu, Y., Huang, P. L., Huffman, J. E., Ikram, M. A., Ingelsson, E., Jackson, A. U., Jansson, J. H., Jarvik, G. P., Jensen, G. B., Jia, Y., Johansson, S., Jørgensen, M. E., Jørgensen, T., Jukema, J. W., Kahali, B., Kahn, R. S., Kähönen, M., Kamstrup, P. R., Kanoni, S., Kaprio, J., Karaleftheri, M., Kardia, S. L. R., Karpe, F., Kathiresan, S., Kee, F., Kiemeney, L. A., Kim, E., Kitajima, H., Komulainen, P., Kooner, J. S., Kooperberg, C., Korhonen, T., Kovacs, P., Kuivaniemi, H., Kutalik, Z., Kuulasmaa, K., Kuusisto, J., Laakso, M., Lakka, T. A., Lamparter, D., Lange, E. M., Lange, L. A., Langenberg, C., Larson, E. B., Lee, N. R., Lehtimäki, T., Lewis, C. E., Li, H., Li, J., Li-Gao, R., Lin, H., Lin, K. H., Lin, L. A., Lin, X., Lind, L., Lindström, J., Linneberg, A., Liu, C. T., Liu, D. J., Liu, Y., Lo, K. S., Lophatananon, A., Lotery, A. J., Loukola, A., Luan, J., Lubitz, S. A., Lyytikäinen, L. P., Männistö, S., Marenne, G., Mazul, A. L., McCarthy, M. I., McKean-Cowdin, R., Medland, S. E., Meidtner, K., Milani, L., Mistry, V., Mitchell, P., Mohlke, K. L., Moilanen, L., Moitry, M., Montgomery, G. W., Mook-Kanamori, D. O., Moore, C., Mori, T. A., Morris, A. D., Morris, A. P., Müller-Nurasyid, M., Munroe, P. B., Nalls, M. A., Narisu, N., Nelson, C. P., Neville, M., Nielsen, S. F., Nikus, K., Njølstad, P. R., Nordestgaard, B. G., Nyholt, D. R., O'Connel, J. R., O'Donoghue, M. L., Olde Loohuis, L. M., Ophoff, R. A., Owen, K. R., Packard, C. J., Padmanabhan, S., Palmer, C. N. A., Palmer, N. D., Pasterkamp, G., Patel, A. P., Pattie, A., Pedersen, O., Peissig, P. L., Peloso, G. M., Pennell, C. E., Perola, M., Perry, J. A., Perry, J. R. B., Pers, T. H., Person, T. N., Peters, A., Petersen, E. R. B., Peyser, P. A., Pirie, A., Polasek, O., Polderman, T. J., Puolijoki, H., Raitakari, O. T., Rasheed, A., Rauramaa, R., Reilly, D. F., Renström, F., Rheinberger, M., Ridker, P. M., Rioux, J. D., Rivas, M. A., Roberts, D. J., Robertson, N. R., Robino, A., Rolandsson, O., Rudan, I., Ruth, K. S., Saleheen, D., Salomaa, V., Samani, N. J., Sapkota, Y., Sattar, N., Schoen, R. E., Schreiner, P. J., Schulze, M. B., Scott, R. A., Segura-Lepe, M. P., Shah, S. H., Sheu, W. H., Sim, X., Slater, A. J., Small, K. S., Smith, A. V., Southam, L., Spector, T. D., Speliotes, E. K., Starr, J. M., Stefansson, K., Steinthorsdottir, V., Stirrups, K. E., Strauch, K., Stringham, H. M., Stumvoll, M., Sun, L., Surendran, P., Swift, A. J., Tada, H., Tansey, K. E., Tardif, J. C., Taylor, K. D., Teumer, A., Thompson, D. J., Thorleifsson, G., Thorsteinsdottir, U., Thuesen, B. H., Tönjes, A., Tromp, G., Trompet, S., Tsafantakis, E., Tuomilehto, J., Tybjaerg-Hansen, A., Tyrer, J. P., Uher, R., Uitterlinden, A. G., Uusitupa, M., Laan, S. W., Duijn, C. M., Leeuwen, N., van Setten, J., Vanhala, M., Varbo, A., Varga, T. V., Varma, R., Velez Edwards, D. R., Vermeulen, S. H., Veronesi, G., Vestergaard, H., Vitart, V., Vogt, T. F., Völker, U., Vuckovic, D., Wagenknecht, L. E., Walker, M., Wallentin, L., Wang, F., Wang, C. A., Wang, S., Wang, Y., Ware, E. B., Wareham, N. J., Warren, H. R., Waterworth, D. M., Wessel, J., White, H. D., Willer, C. J., Wilson, J. G., Witte, D. R., Wood, A. R., Wu, Y., Yaghootkar, H., Yao, J., Yao, P., Yerges-Armstrong, L. M., Young, R., Zeggini, E., Zhan, X., Zhang, W., Zhao, J. H., Zhao, W., Zhao, W., Zhou, W., Zondervan, K. T., Rotter, J. I., Pospisilik, J. A., Rivadeneira, F., Borecki, I. B., Deloukas, P., Frayling, T. M., Lettre, G., North, K. E., Lindgren, C. M., Hirschhorn, J. N., & Loos, R. J. F. (2018). Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. Nature genetics, 50(1), 26-41. https://doi.org/10.1038/s41588-017-0011-x
Turcot, Valérie, et al. "Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity." Nature genetics vol. 50,1 (2018): 26-41. doi: https://doi.org/10.1038/s41588-017-0011-x
Turcot V, Lu Y, Highland HM, Schurmann C, Justice AE, Fine RS, Bradfield JP, Esko T, Giri A, Graff M, Guo X, Hendricks AE, Karaderi T, Lempradl A, Locke AE, Mahajan A, Marouli E, Sivapalaratnam S, Young KL, Alfred T, Feitosa MF, Masca NGD, Manning AK, Medina-Gomez C, Mudgal P, Ng MCY, Reiner AP, Vedantam S, Willems SM, Winkler TW, Abecasis G, Aben KK, Alam DS, Alharthi SE, Allison M, Amouyel P, Asselbergs FW, Auer PL, Balkau B, Bang LE, Barroso I, Bastarache L, Benn M, Bergmann S, Bielak LF, Blüher M, Boehnke M, Boeing H, Boerwinkle E, Böger CA, Bork-Jensen J, Bots ML, Bottinger EP, Bowden DW, Brandslund I, Breen G, Brilliant MH, Broer L, Brumat M, Burt AA, Butterworth AS, Campbell PT, Cappellani S, Carey DJ, Catamo E, Caulfield MJ, Chambers JC, Chasman DI, Chen YI, Chowdhury R, Christensen C, Chu AY, Cocca M, Collins FS, Cook JP, Corley J, Corominas Galbany J, Cox AJ, Crosslin DS, Cuellar-Partida G, D'Eustacchio A, Danesh J, Davies G, Bakker PIW, Groot MCH, Mutsert R, Deary IJ, Dedoussis G, Demerath EW, Heijer M, Hollander AI, Ruijter HM, Dennis JG, Denny JC, Di Angelantonio E, Drenos F, Du M, Dubé MP, Dunning AM, Easton DF, Edwards TL, Ellinghaus D, Ellinor PT, Elliott P, Evangelou E, Farmaki AE, Farooqi IS, Faul JD, Fauser S, Feng S, Ferrannini E, Ferrieres J, Florez JC, Ford I, Fornage M, Franco OH, Franke A, Franks PW, Friedrich N, Frikke-Schmidt R, Galesloot TE, Gan W, Gandin I, Gasparini P, Gibson J, Giedraitis V, Gjesing AP, Gordon-Larsen P, Gorski M, Grabe HJ, Grant SFA, Grarup N, Griffiths HL, Grove ML, Gudnason V, Gustafsson S, Haessler J, Hakonarson H, Hammerschlag AR, Hansen T, Harris KM, Harris TB, Hattersley AT, Have CT, Hayward C, He L, Heard-Costa NL, Heath AC, Heid IM, Helgeland Ø, Hernesniemi J, Hewitt AW, Holmen OL, Hovingh GK, Howson JMM, Hu Y, Huang PL, Huffman JE, Ikram MA, Ingelsson E, Jackson AU, Jansson JH, Jarvik GP, Jensen GB, Jia Y, Johansson S, Jørgensen ME, Jørgensen T, Jukema JW, Kahali B, Kahn RS, Kähönen M, Kamstrup PR, Kanoni S, Kaprio J, Karaleftheri M, Kardia SLR, Karpe F, Kathiresan S, Kee F, Kiemeney LA, Kim E, Kitajima H, Komulainen P, Kooner JS, Kooperberg C, Korhonen T, Kovacs P, Kuivaniemi H, Kutalik Z, Kuulasmaa K, Kuusisto J, Laakso M, Lakka TA, Lamparter D, Lange EM, Lange LA, Langenberg C, Larson EB, Lee NR, Lehtimäki T, Lewis CE, Li H, Li J, Li-Gao R, Lin H, Lin KH, Lin LA, Lin X, Lind L, Lindström J, Linneberg A, Liu CT, Liu DJ, Liu Y, Lo KS, Lophatananon A, Lotery AJ, Loukola A, Luan J, Lubitz SA, Lyytikäinen LP, Männistö S, Marenne G, Mazul AL, McCarthy MI, McKean-Cowdin R, Medland SE, Meidtner K, Milani L, Mistry V, Mitchell P, Mohlke KL, Moilanen L, Moitry M, Montgomery GW, Mook-Kanamori DO, Moore C, Mori TA, Morris AD, Morris AP, Müller-Nurasyid M, Munroe PB, Nalls MA, Narisu N, Nelson CP, Neville M, Nielsen SF, Nikus K, Njølstad PR, Nordestgaard BG, Nyholt DR, O'Connel JR, O'Donoghue ML, Olde Loohuis LM, Ophoff RA, Owen KR, Packard CJ, Padmanabhan S, Palmer CNA, Palmer ND, Pasterkamp G, Patel AP, Pattie A, Pedersen O, Peissig PL, Peloso GM, Pennell CE, Perola M, Perry JA, Perry JRB, Pers TH, Person TN, Peters A, Petersen ERB, Peyser PA, Pirie A, Polasek O, Polderman TJ, Puolijoki H, Raitakari OT, Rasheed A, Rauramaa R, Reilly DF, Renström F, Rheinberger M, Ridker PM, Rioux JD, Rivas MA, Roberts DJ, Robertson NR, Robino A, Rolandsson O, Rudan I, Ruth KS, Saleheen D, Salomaa V, Samani NJ, Sapkota Y, Sattar N, Schoen RE, Schreiner PJ, Schulze MB, Scott RA, Segura-Lepe MP, Shah SH, Sheu WH, Sim X, Slater AJ, Small KS, Smith AV, Southam L, Spector TD, Speliotes EK, Starr JM, Stefansson K, Steinthorsdottir V, Stirrups KE, Strauch K, Stringham HM, Stumvoll M, Sun L, Surendran P, Swift AJ, Tada H, Tansey KE, Tardif JC, Taylor KD, Teumer A, Thompson DJ, Thorleifsson G, Thorsteinsdottir U, Thuesen BH, Tönjes A, Tromp G, Trompet S, Tsafantakis E, Tuomilehto J, Tybjaerg-Hansen A, Tyrer JP, Uher R, Uitterlinden AG, Uusitupa M, Laan SW, Duijn CM, Leeuwen N, van Setten J, Vanhala M, Varbo A, Varga TV, Varma R, Velez Edwards DR, Vermeulen SH, Veronesi G, Vestergaard H, Vitart V, Vogt TF, Völker U, Vuckovic D, Wagenknecht LE, Walker M, Wallentin L, Wang F, Wang CA, Wang S, Wang Y, Ware EB, Wareham NJ, Warren HR, Waterworth DM, Wessel J, White HD, Willer CJ, Wilson JG, Witte DR, Wood AR, Wu Y, Yaghootkar H, Yao J, Yao P, Yerges-Armstrong LM, Young R, Zeggini E, Zhan X, Zhang W, Zhao JH, Zhao W, Zhao W, Zhou W, Zondervan KT, Rotter JI, Pospisilik JA, Rivadeneira F, Borecki IB, Deloukas P, Frayling TM, Lettre G, North KE, Lindgren CM, Hirschhorn JN, Loos RJF. Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity. Nat Genet. 2018 Jan;50(1):26-41. doi: 10.1038/s41588-017-0011-x. Epub 2017 Dec 22. PMID: 29273807; PMCID: PMC5945951.
Copy Download .nbib Format: NLM
Share it on

Nat Genet. 2018 Jan;50(1):26-41. doi: 10.1038/s41588-017-0011-x. Epub 2017 Dec 22.

Protein-altering variants associated with body mass index implicate pathways that control energy intake and expenditure in obesity.

Nature genetics

Valérie Turcot, Yingchang Lu, Heather M Highland, Claudia Schurmann, Anne E Justice, Rebecca S Fine, Jonathan P Bradfield, Tõnu Esko, Ayush Giri, Mariaelisa Graff, Xiuqing Guo, Audrey E Hendricks, Tugce Karaderi, Adelheid Lempradl, Adam E Locke, Anubha Mahajan, Eirini Marouli, Suthesh Sivapalaratnam, Kristin L Young, Tamuno Alfred, Mary F Feitosa, Nicholas G D Masca, Alisa K Manning, Carolina Medina-Gomez, Poorva Mudgal, Maggie C Y Ng, Alex P Reiner, Sailaja Vedantam, Sara M Willems, Thomas W Winkler, Gonçalo Abecasis, Katja K Aben, Dewan S Alam, Sameer E Alharthi, Matthew Allison, Philippe Amouyel, Folkert W Asselbergs, Paul L Auer, Beverley Balkau, Lia E Bang, Inês Barroso, Lisa Bastarache, Marianne Benn, Sven Bergmann, Lawrence F Bielak, Matthias Blüher, Michael Boehnke, Heiner Boeing, Eric Boerwinkle, Carsten A Böger, Jette Bork-Jensen, Michiel L Bots, Erwin P Bottinger, Donald W Bowden, Ivan Brandslund, Gerome Breen, Murray H Brilliant, Linda Broer, Marco Brumat, Amber A Burt, Adam S Butterworth, Peter T Campbell, Stefania Cappellani, David J Carey, Eulalia Catamo, Mark J Caulfield, John C Chambers, Daniel I Chasman, Yii-Der I Chen, Rajiv Chowdhury, Cramer Christensen, Audrey Y Chu, Massimiliano Cocca, Francis S Collins, James P Cook, Janie Corley, Jordi Corominas Galbany, Amanda J Cox, David S Crosslin, Gabriel Cuellar-Partida, Angela D'Eustacchio, John Danesh, Gail Davies, Paul I W Bakker, Mark C H Groot, Renée Mutsert, Ian J Deary, George Dedoussis, Ellen W Demerath, Martin Heijer, Anneke I Hollander, Hester M Ruijter, Joe G Dennis, Josh C Denny, Emanuele Di Angelantonio, Fotios Drenos, Mengmeng Du, Marie-Pierre Dubé, Alison M Dunning, Douglas F Easton, Todd L Edwards, David Ellinghaus, Patrick T Ellinor, Paul Elliott, Evangelos Evangelou, Aliki-Eleni Farmaki, I Sadaf Farooqi, Jessica D Faul, Sascha Fauser, Shuang Feng, Ele Ferrannini, Jean Ferrieres, Jose C Florez, Ian Ford, Myriam Fornage, Oscar H Franco, Andre Franke, Paul W Franks, Nele Friedrich, Ruth Frikke-Schmidt, Tessel E Galesloot, Wei Gan, Ilaria Gandin, Paolo Gasparini, Jane Gibson, Vilmantas Giedraitis, Anette P Gjesing, Penny Gordon-Larsen, Mathias Gorski, Hans-Jörgen Grabe, Struan F A Grant, Niels Grarup, Helen L Griffiths, Megan L Grove, Vilmundur Gudnason, Stefan Gustafsson, Jeff Haessler, Hakon Hakonarson, Anke R Hammerschlag, Torben Hansen, Kathleen Mullan Harris, Tamara B Harris, Andrew T Hattersley, Christian T Have, Caroline Hayward, Liang He, Nancy L Heard-Costa, Andrew C Heath, Iris M Heid, Øyvind Helgeland, Jussi Hernesniemi, Alex W Hewitt, Oddgeir L Holmen, G Kees Hovingh, Joanna M M Howson, Yao Hu, Paul L Huang, Jennifer E Huffman, M Arfan Ikram, Erik Ingelsson, Anne U Jackson, Jan-Håkan Jansson, Gail P Jarvik, Gorm B Jensen, Yucheng Jia, Stefan Johansson, Marit E Jørgensen, Torben Jørgensen, J Wouter Jukema, Bratati Kahali, René S Kahn, Mika Kähönen, Pia R Kamstrup, Stavroula Kanoni, Jaakko Kaprio, Maria Karaleftheri, Sharon L R Kardia, Fredrik Karpe, Sekar Kathiresan, Frank Kee, Lambertus A Kiemeney, Eric Kim, Hidetoshi Kitajima, Pirjo Komulainen, Jaspal S Kooner, Charles Kooperberg, Tellervo Korhonen, Peter Kovacs, Helena Kuivaniemi, Zoltán Kutalik, Kari Kuulasmaa, Johanna Kuusisto, Markku Laakso, Timo A Lakka, David Lamparter, Ethan M Lange, Leslie A Lange, Claudia Langenberg, Eric B Larson, Nanette R Lee, Terho Lehtimäki, Cora E Lewis, Huaixing Li, Jin Li, Ruifang Li-Gao, Honghuang Lin, Keng-Hung Lin, Li-An Lin, Xu Lin, Lars Lind, Jaana Lindström, Allan Linneberg, Ching-Ti Liu, Dajiang J Liu, Yongmei Liu, Ken S Lo, Artitaya Lophatananon, Andrew J Lotery, Anu Loukola, Jian'an Luan, Steven A Lubitz, Leo-Pekka Lyytikäinen, Satu Männistö, Gaëlle Marenne, Angela L Mazul, Mark I McCarthy, Roberta McKean-Cowdin, Sarah E Medland, Karina Meidtner, Lili Milani, Vanisha Mistry, Paul Mitchell, Karen L Mohlke, Leena Moilanen, Marie Moitry, Grant W Montgomery, Dennis O Mook-Kanamori, Carmel Moore, Trevor A Mori, Andrew D Morris, Andrew P Morris, Martina Müller-Nurasyid, Patricia B Munroe, Mike A Nalls, Narisu Narisu, Christopher P Nelson, Matt Neville, Sune F Nielsen, Kjell Nikus, Pål R Njølstad, Børge G Nordestgaard, Dale R Nyholt, Jeffrey R O'Connel, Michelle L O'Donoghue, Loes M Olde Loohuis, Roel A Ophoff, Katharine R Owen, Chris J Packard, Sandosh Padmanabhan, Colin N A Palmer, Nicholette D Palmer, Gerard Pasterkamp, Aniruddh P Patel, Alison Pattie, Oluf Pedersen, Peggy L Peissig, Gina M Peloso, Craig E Pennell, Markus Perola, James A Perry, John R B Perry, Tune H Pers, Thomas N Person, Annette Peters, Eva R B Petersen, Patricia A Peyser, Ailith Pirie, Ozren Polasek, Tinca J Polderman, Hannu Puolijoki, Olli T Raitakari, Asif Rasheed, Rainer Rauramaa, Dermot F Reilly, Frida Renström, Myriam Rheinberger, Paul M Ridker, John D Rioux, Manuel A Rivas, David J Roberts, Neil R Robertson, Antonietta Robino, Olov Rolandsson, Igor Rudan, Katherine S Ruth, Danish Saleheen, Veikko Salomaa, Nilesh J Samani, Yadav Sapkota, Naveed Sattar, Robert E Schoen, Pamela J Schreiner, Matthias B Schulze, Robert A Scott, Marcelo P Segura-Lepe, Svati H Shah, Wayne H-H Sheu, Xueling Sim, Andrew J Slater, Kerrin S Small, Albert V Smith, Lorraine Southam, Timothy D Spector, Elizabeth K Speliotes, John M Starr, Kari Stefansson, Valgerdur Steinthorsdottir, Kathleen E Stirrups, Konstantin Strauch, Heather M Stringham, Michael Stumvoll, Liang Sun, Praveen Surendran, Amy J Swift, Hayato Tada, Katherine E Tansey, Jean-Claude Tardif, Kent D Taylor, Alexander Teumer, Deborah J Thompson, Gudmar Thorleifsson, Unnur Thorsteinsdottir, Betina H Thuesen, Anke Tönjes, Gerard Tromp, Stella Trompet, Emmanouil Tsafantakis, Jaakko Tuomilehto, Anne Tybjaerg-Hansen, Jonathan P Tyrer, Rudolf Uher, André G Uitterlinden, Matti Uusitupa, Sander W Laan, Cornelia M Duijn, Nienke Leeuwen, Jessica van Setten, Mauno Vanhala, Anette Varbo, Tibor V Varga, Rohit Varma, Digna R Velez Edwards, Sita H Vermeulen, Giovanni Veronesi, Henrik Vestergaard, Veronique Vitart, Thomas F Vogt, Uwe Völker, Dragana Vuckovic, Lynne E Wagenknecht, Mark Walker, Lars Wallentin, Feijie Wang, Carol A Wang, Shuai Wang, Yiqin Wang, Erin B Ware, Nicholas J Wareham, Helen R Warren, Dawn M Waterworth, Jennifer Wessel, Harvey D White, Cristen J Willer, James G Wilson, Daniel R Witte, Andrew R Wood, Ying Wu, Hanieh Yaghootkar, Jie Yao, Pang Yao, Laura M Yerges-Armstrong, Robin Young, Eleftheria Zeggini, Xiaowei Zhan, Weihua Zhang, Jing Hua Zhao, Wei Zhao, Wei Zhao, Wei Zhou, Krina T Zondervan, Jerome I Rotter, John A Pospisilik, Fernando Rivadeneira, Ingrid B Borecki, Panos Deloukas, Timothy M Frayling, Guillaume Lettre, Kari E North, Cecilia M Lindgren, Joel N Hirschhorn, Ruth J F Loos

Affiliations

  1. Montreal Heart Institute, Université de Montréal, Montreal, Quebec, Canada.
  2. Division of Epidemiology, Department of Medicine, Vanderbilt-Ingram Cancer Center, Vanderbilt Epidemiology Center, Vanderbilt University School of Medicine, Nashville, TN, USA.
  3. Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  4. Genetics of Obesity and Related Metabolic Traits Program, Icahn School of Medicine at Mount Sinai, New York, NY, USA.
  5. Department of Epidemiology, University of North Carolina, Chapel Hill, NC, USA.
  6. Human Genetics Center, University of Texas School of Public Health, University of Texas MD Anderson Cancer Center UTHealth Graduate School of Biomedical Sciences, University of Texas Health Science Center at Houston, Houston, TX, USA.
  7. Broad Institute of MIT and Harvard, Cambridge, MA, USA.
  8. Department of Genetics, Harvard Medical School, Boston, MA, USA.
  9. Division of Endocrinology and Center for Basic and Translational Obesity Research, Boston Children's Hospital, Boston, MA, USA.
  10. Center for Applied Genomics, Division of Human Genetics, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  11. Quantinuum Research, LLC, San Diego, CA, USA.
  12. Estonian Genome Center, University of Tartu, Tartu, Estonia.
  13. Division of Epidemiology, Department of Medicine, Institute for Medicine and Public Health, Vanderbilt Genetics Institute, Vanderbilt University, Nashville, TN, USA.
  14. Institute for Translational Genomics and Population Sciences, LABioMed at Harbor-UCLA Medical Center, Torrance, CA, USA.
  15. Wellcome Trust Sanger Institute, Hinxton, UK.
  16. Department of Mathematical and Statistical Sciences, University of Colorado, Denver, CO, USA.
  17. Wellcome Trust Centre for Human Genetics, University of Oxford, Oxford, UK.
  18. Department of Biological Sciences, Faculty of Arts and Sciences, Eastern Mediterranean University, Famagusta, Cyprus.
  19. Max Planck Institute of Immunobiology and Epigenetics, Freiburg, Germany.
  20. Department of Biostatistics and Center for Statistical Genetics, University of Michigan, Ann Arbor, MI, USA.
  21. McDonnell Genome Institute, Washington University School of Medicine, St. Louis, MO, USA.
  22. William Harvey Research Institute, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  23. Department of Vascular Medicine, AMC, Amsterdam, The Netherlands.
  24. Massachusetts General Hospital, Boston, MA, USA.
  25. Department of Haematology, University of Cambridge, Cambridge, UK.
  26. Division of Statistical Genomics, Department of Genetics, Washington University School of Medicine, St. Louis, MO, USA.
  27. Department of Cardiovascular Sciences, University of Leicester, Glenfield Hospital, Leicester, UK.
  28. NIHR Leicester Cardiovascular Biomedical Research Unit, Glenfield Hospital, Leicester, UK.
  29. Department of Medicine, Harvard Medical School, Boston, MA, USA.
  30. Medical and Population Genetics Program, Broad Institute, Cambridge, MA, USA.
  31. Department of Epidemiology, Erasmus Medical Center, Rotterdam, The Netherlands.
  32. Department of Internal Medicine, Erasmus Medical Center, Rotterdam, The Netherlands.
  33. Center for Diabetes Research, Wake Forest School of Medicine, Winston-Salem, NC, USA.
  34. Center for Genomics and Personalized Medicine Research, Wake Forest School of Medicine, Winston-Salem, NC, USA.
  35. Department of Epidemiology, University of Washington, Seattle, WA, USA.
  36. Division of Public Health Sciences, Fred Hutchinson Cancer Research Center, Seattle, WA, USA.
  37. MRC Epidemiology Unit, University of Cambridge School of Clinical Medicine, Institute of Metabolic Science, Cambridge, UK.
  38. Department of Genetic Epidemiology, University of Regensburg, Regensburg, Germany.
  39. Netherlands Comprehensive Cancer Organisation, Utrecht, The Netherlands.
  40. Radboud Institute for Health Sciences, Radboud University Medical Center, Nijmegen, The Netherlands.
  41. School of Kinesiology and Health Science, Faculty of Health, York University, Toronto, Ontario, Canada.
  42. Princess Al-Jawhara Al-Brahim Centre of Excellence in Research of Hereditary Disorders (PACER-HD), King Abdulaziz University, Jeddah, Saudi Arabia.
  43. Department of Family Medicine and Public Health, University of California, San Diego, La Jolla, CA, USA.
  44. INSERM U1167, Lille, France.
  45. Institut Pasteur de Lille, U1167, Lille, France.
  46. Université de Lille, U1167, RID-AGE, Risk Factors and Molecular Determinants of Aging-Related Diseases, Lille, France.
  47. Department of Cardiology, Division Heart and Lungs, University Medical Center Utrecht, Utrecht, The Netherlands.
  48. Durrer Center for Cardiogenetic Research, ICIN-Netherlands Heart Institute, Utrecht, The Netherlands.
  49. Institute of Cardiovascular Science, Faculty of Population Health Sciences, University College London, London, UK.
  50. Zilber School of Public Health, University of Wisconsin-Milwaukee, Milwaukee, WI, USA.
  51. INSERM U1018, Centre de Recherche en Épidémiologie et Santé des Populations (CESP), Villejuif, France.
  52. Department of Cardiology, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  53. Metabolic Research Laboratories, University of Cambridge, Cambridge, UK.
  54. NIHR Cambridge Biomedical Research Centre, Wellcome Trust-MRC Institute of Metabolic Science, Addenbrooke's Hospital, Cambridge, UK.
  55. Department of Biomedical Informatics, Vanderbilt University, Nashville, TN, USA.
  56. Department of Clinical Biochemistry, Herlev and Gentofte Hospital, Copenhagen University Hospital, Herlev, Denmark.
  57. Department of Public Health, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  58. Department of Computational Biology, University of Lausanne, Lausanne, Switzerland.
  59. Swiss Institute of Bioinformatics, Lausanne, Switzerland.
  60. Department of Epidemiology, School of Public Health, University of Michigan, Ann Arbor, MI, USA.
  61. IFB Adiposity Diseases, University of Leipzig, Leipzig, Germany.
  62. Department of Medicine, University of Leipzig, Leipzig, Germany.
  63. Department of Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrücke (DIfE), Nuthetal, Germany.
  64. School of Public Health, Human Genetics Center, University of Texas Health Science Center at Houston, Houston, TX, USA.
  65. Human Genome Sequencing Center, Baylor College of Medicine, Houston, TX, USA.
  66. Department of Nephrology, University Hospital Regensburg, Regensburg, Germany.
  67. Novo Nordisk Foundation Center for Basic Metabolic Research, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  68. Julius Center for Health Sciences and Primary Care, University Medical Center Utrecht, Utrecht, The Netherlands.
  69. Department of Biochemistry, Wake Forest School of Medicine, Winston-Salem, NC, USA.
  70. Department of Clinical Biochemistry, Lillebaelt Hospital, Vejle, Denmark.
  71. Institute of Regional Health Research, University of Southern Denmark, Odense, Denmark.
  72. MRC Social Genetic and Developmental Psychiatry Centre, Institute of Psychiatry, Psychology and Neuroscience, King's College London, London, UK.
  73. NIHR Biomedical Research Centre for Mental Health, South London and Maudsley Hospital, London, UK.
  74. Marshfield Clinic Research Institute, Marshfield, WI, USA.
  75. Department of Medical Sciences, University of Trieste, Trieste, Italy.
  76. Department of Medicine, University of Washington, Seattle, WA, USA.
  77. MRC/BHF Cardiovascular Epidemiology Unit, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  78. NIHR Blood and Transplant Research Unit in Donor Health and Genomics, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  79. Epidemiology Research Program, American Cancer Society, Atlanta, GA, USA.
  80. Institute for Maternal and Child Health, IRCCS 'Burlo Garofolo', Trieste, Italy.
  81. Weis Center for Research, Geisinger Health System, Danville, PA, USA.
  82. NIHR Barts Cardiovascular Research Unit, Barts and The London School of Medicine and Dentistry, Queen Mary University of London, London, UK.
  83. Department of Cardiology, London North West Healthcare NHS Trust, Ealing Hospital, Middlesex, UK.
  84. Department of Epidemiology and Biostatistics, School of Public Health, Imperial College London, London, UK.
  85. Imperial College Healthcare NHS Trust, London, UK.
  86. Division of Genetics, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  87. Division of Preventive Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  88. Harvard Medical School, Boston, MA, USA.
  89. Medical Department, Lillebaelt Hospital, Vejle, Denmark.
  90. NHLBI Framingham Heart Study, Framingham, MA, USA.
  91. Genetics and Pharmacogenomics, Merck, Sharp & Dohme, Boston, MA, USA.
  92. Department of Medical, Surgical and Health Sciences, University of Trieste, Trieste, Italy.
  93. Medical Genomics and Metabolic Genetics Branch, National Human Genome Research Institute, US National Institutes of Health, Bethesda, MD, USA.
  94. Department of Biostatistics, University of Liverpool, Liverpool, UK.
  95. Centre for Cognitive Ageing and Cognitive Epidemiology, University of Edinburgh, Edinburgh, UK.
  96. Department of Psychology, University of Edinburgh, Edinburgh, UK.
  97. Department of Human Genetics, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
  98. Department of Ophthalmology, Donders Institute for Brain, Cognition and Behaviour, Radboud University Medical Center, Nijmegen, The Netherlands.
  99. Menzies Health Institute Queensland, Griffith University, Southport, Queensland, Australia.
  100. Department of Biomedical Informatics and Medical Education, University of Washington, Seattle, WA, USA.
  101. Diamantina Institute, University of Queensland, Brisbane, Queensland, Australia.
  102. QIMR Berghofer Medical Research Institute, Brisbane, Queensland, Australia.
  103. British Heart Foundation Cambridge Centre of Excellence, Department of Medicine, University of Cambridge, Cambridge, UK.
  104. Department of Genetics, Center for Molecular Medicine, University Medical Center Utrecht, Utrecht, The Netherlands.
  105. Department of Clinical Chemistry and Haematology, Division of Laboratory and Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands.
  106. Utrecht Institute for Pharmaceutical Sciences, Division Pharmacoepidemiology and Clinical Pharmacology, Utrecht University, Utrecht, The Netherlands.
  107. Department of Clinical Epidemiology, Leiden University Medical Center, Leiden, The Netherlands.
  108. Department of Nutrition and Dietetics, School of Health Science and Education, Harokopio University, Athens, Greece.
  109. Division of Epidemiology and Community Health, School of Public Health, University of Minnesota, Minneapolis, MN, USA.
  110. Department of Internal Medicine, VU University Medical Center, Amsterdam, The Netherlands.
  111. Laboratory of Experimental Cardiology, Division Heart and Lungs, University Medical Center Utrecht, Utrecht, The Netherlands.
  112. Centre for Cancer Genetic Epidemiology, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  113. Institute of Cardiovascular Science, University College London, London, UK.
  114. MRC Integrative Epidemiology Unit, School of Social and Community Medicine, University of Bristol, Bristol, UK.
  115. Department of Epidemiology and Biostatistics, Memorial Sloan Kettering Cancer Center, New York, NY, USA.
  116. Department of Medicine, Faculty of Medicine, Université de Montréal, Montreal, Quebec, Canada.
  117. Centre for Cancer Genetic Epidemiology, Department of Oncology, University of Cambridge, Cambridge, UK.
  118. Institute of Clinical Molecular Biology, Christian Albrechts University of Kiel, Kiel, Germany.
  119. Department of Epidemiology and Biostatistics, MRC-PHE Centre for Environment and Health, School of Public Health, Imperial College London, London, UK.
  120. Department of Hygiene and Epidemiology, University of Ioannina Medical School, Ioannina, Greece.
  121. Department of Health Sciences, University of Leicester, Leicester, UK.
  122. Survey Research Center, Institute for Social Research, University of Michigan, Ann Arbor, MI, USA.
  123. Department of Ophthalmology, University of Cologne, Cologne, Germany.
  124. CNR Institute of Clinical Physiology, Pisa, Italy.
  125. Department of Clinical and Experimental Medicine, University of Pisa, Pisa, Italy.
  126. Toulouse University School of Medicine, Toulouse, France.
  127. University of Glasgow, Glasgow, UK.
  128. Institute of Molecular Medicine, University of Texas Health Science Center at Houston, Houston, TX, USA.
  129. Department of Clinical Sciences, Genetic and Molecular Epidemiology Unit, Lund University, Malmo, Sweden.
  130. Department of Nutrition, Harvard School of Public Health, Boston, MA, USA.
  131. Department of Public Health and Clinical Medicine, Unit of Medicine, Umeå University, Umeå, Sweden.
  132. Institute of Clinical Chemistry and Laboratory Medicine, University Medicine Greifswald, Greifswald, Germany.
  133. Department of Clinical Biochemistry, Rigshospitalet, Copenhagen University Hospital, Copenhagen, Denmark.
  134. Research Unit, AREA Science Park, Trieste, Italy.
  135. Centre for Biological Sciences, Faculty of Natural and Environmental Sciences, University of Southampton, Southampton, UK.
  136. Geriatrics, Department of Public Health, Uppsala University, Uppsala, Sweden.
  137. Carolina Population Center, University of North Carolina, Chapel Hill, NC, USA.
  138. Department of Nutrition, Gillings School of Global Public Health, University of North Carolina, Chapel Hill, NC, USA.
  139. Department of Psychiatry and Psychotherapy, University Medicine Greifswald, Greifswald, Germany.
  140. German Center for Neurodegenerative Diseases (DZNE), Rostock/Greifswald, Greifswald, Germany.
  141. Department of Pediatrics, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  142. Division of Endocrinology, Children's Hospital of Philadelphia, Philadelphia, PA, USA.
  143. Vision Sciences, Clinical Neurosciences Research Group, Faculty of Medicine, University of Southampton, Southampton, UK.
  144. Faculty of Medicine, University of Iceland, Reykjavik, Iceland.
  145. Icelandic Heart Association, Kopavogur, Iceland.
  146. Department of Medical Sciences, Molecular Epidemiology and Science for Life Laboratory, Uppsala University, Uppsala, Sweden.
  147. Department of Complex Trait Genetics, Center for Neurogenomics and Cognitive Research, Amsterdam Neuroscience, VU University Amsterdam, Amsterdam, The Netherlands.
  148. Department of Sociology, University of North Carolina, Chapel Hill, NC, USA.
  149. Laboratory of Epidemiology and Population Sciences, National Institute on Aging, Intramural Research Program, US National Institutes of Health, Bethesda, MD, USA.
  150. University of Exeter Medical School, University of Exeter, Exeter, UK.
  151. MRC Human Genetics Unit, Institute of Genetics and Molecular Medicine, University of Edinburgh, Edinburgh, UK.
  152. Biodemography of Aging Research Unit, Social Science Research Institute, Duke University, Durham, NC, USA.
  153. Department of Public Health, University of Helsinki, Helsinki, Finland.
  154. Department of Neurology, Boston University School of Medicine, Boston, MA, USA.
  155. Department of Psychiatry, Washington University, St. Louis, MO, USA.
  156. Institute of Genetic Epidemiology, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany.
  157. Department of Pediatrics, Haukeland University Hospital, Bergen, Norway.
  158. KG Jebsen Center for Diabetes Research, Department of Clinical Science, University of Bergen, Bergen, Norway.
  159. Department of Cardiology, Heart Center, Tampere University Hospital and Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
  160. Department of Clinical Chemistry, Fimlab Laboratories, Tampere, Finland.
  161. Department of Clinical Chemistry, Finnish Cardiovascular Research Center-Tampere, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
  162. Centre for Eye Research Australia, Royal Victorian Eye and Ear Hospital, University of Melbourne, Melbourne, Victoria, Australia.
  163. Centre for Ophthalmology and Vision Science, Lions Eye Institute, University of Western Australia, Perth, Western Australia, Australia.
  164. Menzies Research Institute Tasmania, University of Tasmania, Hobart, Tasmania, Australia.
  165. KG Jebsen Center for Genetic Epidemiology, Department of Public Health, NTNU, Norwegian University of Science and Technology, Trondheim, Norway.
  166. Key Laboratory of Nutrition and Metabolism, Institute for Nutritional Sciences, Shanghai Institutes for Biological Sciences, Chinese Academy of Sciences, University of the Chinese Academy of Sciences, Shanghai, China.
  167. Department of Neurology, Erasmus Medical Center, Rotterdam, The Netherlands.
  168. Department of Radiology, Erasmus Medical Center, Rotterdam, The Netherlands.
  169. Division of Cardiovascular Medicine, Department of Medicine, Stanford University School of Medicine, Stanford, CA, USA.
  170. Department of Public Health and Clinical Medicine, Umeå University, Umeå, Sweden.
  171. Research Unit Skellefteå, Skellefteå, Sweden.
  172. Department of Genome Sciences, University of Washington, Seattle, WA, USA.
  173. Copenhagen City Heart Study, Frederiksberg Hospital, Frederiksberg, Denmark.
  174. Center for Medical Genetics and Molecular Medicine, Haukeland University Hospital, Bergen, Norway.
  175. National Institute of Public Health, University of Southern Denmark, Copenhagen, Denmark.
  176. Steno Diabetes Center Copenhagen, Gentofte, Denmark.
  177. Faculty of Medicine, Aalborg University, Aalborg, Denmark.
  178. Research Center for Prevention and Health, Capital Region of Denmark, Glostrup, Denmark.
  179. Department of Cardiology, Leiden University Medical Center, Leiden, The Netherlands.
  180. Interuniversity Cardiology Institute of the Netherlands, Utrecht, The Netherlands.
  181. Department of Computational Medicine and Bioinformatics, University of Michigan, Ann Arbor, MI, USA.
  182. Department of Internal Medicine, University of Michigan, Ann Arbor, MI, USA.
  183. Division of Gastroenterology, University of Michigan, Ann Arbor, MI, USA.
  184. Centre for Brain Research, Indian Institute of Science, Bangalore, India.
  185. Department of Psychiatry, Brain Center Rudolf Magnus, University Medical Center Utrecht, Utrecht, The Netherlands.
  186. Department of Clinical Physiology, Faculty of Medicine and Life Sciences, University of Tampere, Tampere, Finland.
  187. Department of Clinical Physiology, Tampere University Hospital, Tampere, Finland.
  188. Institute for Molecular Medicine Finland (FIMM), University of Helsinki, Helsinki, Finland.
  189. National Institute for Health and Welfare, Helsinki, Finland.
  190. Echinos Medical Centre, Echinos, Greece.
  191. Oxford Centre for Diabetes, Endocrinology and Metabolism, Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
  192. Oxford NIHR Biomedical Research Centre, Oxford University Hospitals Trust, Oxford, UK.
  193. UKCRC Centre of Excellence for Public Health Research, Queens University Belfast, Belfast, UK.
  194. Foundation for Research in Health Exercise and Nutrition, Kuopio Research Institute of Exercise Medicine, Kuopio, Finland.
  195. Institute of Biomedicine, School of Medicine, University of Eastern Finland, Kuopio Campus, Kuopio, Finland.
  196. Department of Clinical Physiology and Nuclear Medicine, Kuopio University Hospital, Kuopio, Finland.
  197. National Heart and Lung Institute, Imperial College London, Hammersmith Hospital Campus, London, UK.
  198. MRC-PHE Centre for Environment and Health, Imperial College London, London, UK.
  199. Institute of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.
  200. Department of Psychiatry, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa.
  201. Division of Molecular Biology and Human Genetics, Department of Biomedical Sciences, Faculty of Medicine and Health Sciences, Stellenbosch University, Tygerberg, South Africa.
  202. Institute of Social and Preventive Medicine, Lausanne University Hospital, Lausanne, Switzerland.
  203. Institute of Clinical Medicine, Internal Medicine, University of Eastern Finland and Kuopio University Hospital, Kuopio, Finland.
  204. Department of Genetics, University of North Carolina, Chapel Hill, NC, USA.
  205. Kaiser Permanente Washington Health Research Institute, Seattle, WA, USA.
  206. Department of Health Services, University of Washington, Seattle, WA, USA.
  207. Department of Anthropology, Sociology and History, University of San Carlos, Cebu City, Philippines.
  208. USC-Office of Population Studies Foundation, Inc., University of San Carlos, Cebu City, Philippines.
  209. Division of Preventive Medicine, University of Alabama at Birmingham, Birmingham, AL, USA.
  210. Department of Medicine, Boston University School of Medicine, Boston, MA, USA.
  211. Department of Ophthalmology, Taichung Veterans General Hospital, Taichung, Taiwan.
  212. Department of Medical Sciences, Cardiovascular Epidemiology, Uppsala University, Uppsala, Sweden.
  213. Department of Clinical Experimental Research, Rigshospitalet, Copenhagen, Denmark.
  214. Department of Clinical Medicine, Faculty of Health and Medical Sciences, University of Copenhagen, Copenhagen, Denmark.
  215. Department of Biostatistics, Boston University School of Public Health, Boston, MA, USA.
  216. Department of Public Health Sciences, Institute for Personalized Medicine, Pennsylvania State University College of Medicine, Hershey, PA, USA.
  217. Division of Public Health Sciences, Wake Forest School of Medicine, Winston-Salem, NC, USA.
  218. Division of Health Sciences, Warwick Medical School, Warwick University, Coventry, UK.
  219. Department of Preventive Medicine, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA.
  220. Department of Molecular Epidemiology, German Institute of Human Nutrition Potsdam-Rehbrücke (DIfE), Nuthetal, Germany.
  221. German Center for Diabetes Research, Neuherberg, Germany.
  222. Westmead Millennium Institute of Medical Research, Centre for Vision Research and Department of Ophthalmology, University of Sydney, Sydney, New South Wales, Australia.
  223. Department of Medicine, Kuopio University Hospital, Kuopio, Finland.
  224. Department of Epidemiology and Public Health, University of Strasbourg, Strasbourg, France.
  225. Department of Public Health, University Hospital of Strasbourg, Strasbourg, France.
  226. Institute for Molecular Bioscience, University of Queensland, Brisbane, Queensland, Australia.
  227. Department of Public Health and Primary Care, Leiden University Medical Center, Leiden, The Netherlands.
  228. INTERVAL Coordinating Centre, Department of Public Health and Primary Care, University of Cambridge, Cambridge, UK.
  229. School of Medicine and Pharmacology, University of Western Australia, Perth, Western Australia, Australia.
  230. Centre for Global Health Research, Usher Institute of Population Health Sciences and Informatics, University of Edinburgh, Edinburgh, UK.
  231. Department of Medicine I, University Hospital Großhadern, Ludwig-Maximilians-Universitat, Munich, Germany.
  232. German Centre for Cardiovascular Research (DZHK), partner site Munich Heart Alliance, Munich, Germany.
  233. Laboratory of Neurogenetics, National Institute on Aging, US National Institutes of Health, Bethesda, MD, USA.
  234. Data Tecnica International, Glen Echo, MD, USA.
  235. Institute of Health and Biomedical Innovation, Queensland University of Technology, Brisbane, Queensland, Australia.
  236. Program for Personalized and Genomic Medicine, Department of Medicine, University of Maryland School of Medicine, Baltimore, MD, USA.
  237. Division of Cardiovascular Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA, USA.
  238. Center for Neurobehavioral Genetics, University of California, Los Angeles, Los Angeles, CA, USA.
  239. Pat Macpherson Centre for Pharmacogenetics and Pharmacogenomics, Medical Research Institute, Ninewells Hospital and Medical School, Dundee, UK.
  240. Laboratory of Clinical Chemistry and Hematology, Division of Laboratories and Pharmacy, University Medical Center Utrecht, Utrecht, The Netherlands.
  241. School of Women's and Infants' Health, University of Western Australia, Perth, Western Australia, Australia.
  242. Diabetes and Obesity Research Program, University of Helsinki, Helsinki, Finland.
  243. Department of Epidemiology Research, Statens Serum Institut, Copenhagen, Denmark.
  244. Institute of Epidemiology II, Helmholtz Zentrum München-German Research Center for Environmental Health, Neuherberg, Germany.
  245. Department of Clinical Immunology and Biochemistry, Lillebaelt Hospital, Vejle, Denmark.
  246. School of Medicine, University of Split, Split, Croatia.
  247. Central Hospital of Southern Ostrobothnia, Seinäjoki, Finland.
  248. Department of Clinical Physiology and Nuclear Medicine, Turku University Hospital, Turku, Finland.
  249. Research Centre of Applied and Preventive Cardiovascular Medicine, University of Turku, Turku, Finland.
  250. Centre for Non-Communicable Diseases, Karachi, Pakistan.
  251. Department of Biobank Research, Umeå University, Umeå, Sweden.
  252. Wellcome Trust Centre for Human Genetics, Nuffield Department of Clinical Medicine, University of Oxford, Oxford, UK.
  253. NHS Blood and Transplant-Oxford Centre, Oxford, UK.
  254. BRC Haematology Theme and Radcliffe Department of Medicine, University of Oxford, Oxford, UK.
  255. Department of Public Health and Clinical Medicine, Unit of Family Medicine, Umeå University, Umeå, Sweden.
  256. Genetics of Complex Traits, University of Exeter Medical School, University of Exeter, Exeter, UK.
  257. Department of Biostatistics and Epidemiology, Perelman School of Medicine, University of Pennsylvania, Philadelphia, PA, USA.
  258. Departments of Medicine and Epidemiology, University of Pittsburgh Medical Center, Pittsburgh, PA, USA.
  259. Duke Molecular Physiology Institute, Duke University, Durham, NC, USA.
  260. Division of Endocrinology and Metabolism, Department of Internal Medicine, Taichung Veterans General Hospital, Taichung, Taiwan.
  261. School of Medicine, National Defense Medical Center, Taipei, Taiwan.
  262. School of Medicine, National Yang-Ming University, Taipei, Taiwan.
  263. Saw Swee Hock School of Public Health, National University Health System, National University of Singapore, Singapore, Singapore.
  264. Genetics, Target Sciences, GlaxoSmithKline, Research Triangle Park, NC, USA.
  265. OmicSoft at Qiagen Company, Cary, NC, USA.
  266. Department of Twin Research and Genetic Epidemiology, King's College London, London, UK.
  267. Alzheimer Scotland Dementia Research Centre, University of Edinburgh, Edinburgh, UK.
  268. deCODE Genetics/Amgen, Inc., Reykjavik, Iceland.
  269. Chair of Genetic Epidemiology, IBE, Faculty of Medicine, LMU Munich, Munich, Germany.
  270. Kanazawa University, Kanazawa, Japan.
  271. College of Biomedical and Life Sciences, Cardiff University, Cardiff, UK.
  272. Institute for Community Medicine, University Medicine Greifswald, Greifswald, Germany.
  273. Center for Pediatric Research, Department for Women's and Child Health, University of Leipzig, Leipzig, Germany.
  274. Department of Gerontology and Geriatrics, Leiden University Medical Center, Leiden, The Netherlands.
  275. Anogia Medical Centre, Anogia, Greece.
  276. Centre for Vascular Prevention, Danube University Krems, Krems, Austria.
  277. Dasman Diabetes Institute, Dasman, Kuwait.
  278. Diabetes Research Group, King Abdulaziz University, Jeddah, Saudi Arabia.
  279. Department of Psychiatry, Dalhousie University, Halifax, Nova Scotia, Canada.
  280. Department of Public Health and Clinical Nutrition, University of Eastern Finland, Kuopio, Finland.
  281. Department of Epidemiology and Biostatistics, VU University Medical Center, Amsterdam, The Netherlands.
  282. Department of Molecular Cell Biology, Leiden University Medical Center, Leiden, The Netherlands.
  283. Primary Health Care Unit, Central Hospital of Central Finland, Jyväskylä, Finland.
  284. Primary Health Care Unit, Kuopio University Hospital, Kuopio, Finland.
  285. USC Roski Eye Institute, Department of Ophthalmology, Keck School of Medicine of the University of Southern California, Los Angeles, CA, USA.
  286. Department of Obstetrics and Gynecology, Institute for Medicine and Public Health, Vanderbilt Genetics Institute, Vanderbilt University, Nashville, TN, USA.
  287. Research Center on Epidemiology and Preventive Medicine, Department of Medicine and Surgery, University of Insubria, Varese, Italy.
  288. Cardiometabolic Disease, Merck, Sharp & Dohme, Kenilworth, NJ, USA.
  289. German Centre for Cardiovascular Research (DZHK), partner site Greifswald, Greifswald, Germany.
  290. Interfaculty Institute for Genetics and Functional Genomics, University Medicine Greifswald, Greifswald, Germany.
  291. Institute of Cellular Medicine, Medical School, Newcastle University, Newcastle, UK.
  292. Department of Medical Sciences, Cardiology, Uppsala Clinical Research Center, Uppsala University, Uppsala, Sweden.
  293. Genetics, Target Sciences, GlaxoSmithKline, King of Prussia, PA, USA.
  294. Departments of Epidemiology and Medicine, Diabetes Translational Research Center, Fairbanks School of Public Health and School of Medicine, Indiana University, Indianapolis, IN, USA.
  295. Green Lane Cardiovascular Service, Auckland City Hospital and University of Auckland, Auckland, New Zealand.
  296. Department of Human Genetics, University of Michigan, Ann Arbor, MI, USA.
  297. Department of Physiology and Biophysics, University of Mississippi Medical Center, Jackson, MS, USA.
  298. Danish Diabetes Academy, Odense, Denmark.
  299. Department of Public Health, Aarhus University, Aarhus, Denmark.
  300. GlaxoSmithKline, King of Prussia, PA, USA.
  301. Department of Clinical Sciences, Quantitative Biomedical Research Center, Center for the Genetics of Host Defense, University of Texas Southwestern Medical Center, Dallas, TX, USA.
  302. Endometriosis CaRe Centre, Nuffield Department of Obstetrics and Gynaecology, University of Oxford, Oxford, UK.
  303. Department of Epidemiology and Carolina Center of Genome Sciences, Chapel Hill, NC, USA.
  304. Li Ka Shing Centre for Health Information and Discovery, Big Data Institute, University of Oxford, Oxford, UK.
  305. Broad Institute of MIT and Harvard, Cambridge, MA, USA. [email protected].
  306. Department of Genetics, Harvard Medical School, Boston, MA, USA. [email protected].
  307. Division of Endocrinology and Center for Basic and Translational Obesity Research, Boston Children's Hospital, Boston, MA, USA. [email protected].
  308. Department of Pediatrics, Harvard Medical School, Boston, MA, USA. [email protected].
  309. Charles Bronfman Institute for Personalized Medicine, Icahn School of Medicine at Mount Sinai, New York, NY, USA. [email protected].
  310. Genetics of Obesity and Related Metabolic Traits Program, Icahn School of Medicine at Mount Sinai, New York, NY, USA. [email protected].
  311. Mindich Child Health and Development Institute, Icahn School of Medicine at Mount Sinai, New York, NY, USA. [email protected].

PMID: 29273807 PMCID: PMC5945951 DOI: 10.1038/s41588-017-0011-x

Abstract

Genome-wide association studies (GWAS) have identified >250 loci for body mass index (BMI), implicating pathways related to neuronal biology. Most GWAS loci represent clusters of common, noncoding variants from which pinpointing causal genes remains challenging. Here we combined data from 718,734 individuals to discover rare and low-frequency (minor allele frequency (MAF) < 5%) coding variants associated with BMI. We identified 14 coding variants in 13 genes, of which 8 variants were in genes (ZBTB7B, ACHE, RAPGEF3, RAB21, ZFHX3, ENTPD6, ZFR2 and ZNF169) newly implicated in human obesity, 2 variants were in genes (MC4R and KSR2) previously observed to be mutated in extreme obesity and 2 variants were in GIPR. The effect sizes of rare variants are ~10 times larger than those of common variants, with the largest effect observed in carriers of an MC4R mutation introducing a stop codon (p.Tyr35Ter, MAF = 0.01%), who weighed ~7 kg more than non-carriers. Pathway analyses based on the variants associated with BMI confirm enrichment of neuronal genes and provide new evidence for adipocyte and energy expenditure biology, widening the potential of genetically supported therapeutic targets in obesity.

References

  1. Bray, G. A. & Ryan, D. H. Update on obesity pharmacotherapy. Ann. NY Acad. Sci. 1311, 1–13 (2014). - PubMed
  2. Bray, G. A., Frühbeck, G., Ryan, D. H. & Wilding, J. P. Management of obesity. Lancet 387, 1947–1956 (2016). - PubMed
  3. Monda, K. L. et al. A meta-analysis identifies new loci associated with body mass index in individuals of African ancestry. Nat. Genet. 45, 690–696 (2013). - PubMed
  4. Wen, W. et al. Meta-analysis of genome-wide association studies in East Asian-ancestry populations identifies four new loci for body mass index. Hum. Mol. Genet. 23, 5492–5504 (2014). - PubMed
  5. Locke, A. E. et al. Genetic studies of body mass index yield new insights for obesity biology. Nature 518, 197–206 (2015). - PubMed
  6. Winkler, T. W. et al. The influence of age and sex on genetic associations with adult body size and shape: a large-scale genome-wide interaction study. PLoS Genet. 11, e1005378 (2015). - PubMed
  7. Akiyama, M. et al. Genome-wide association study identifies 112 new loci for body mass index in the Japanese population. Nat. Genet. 49, 1458–1467 (2017). - PubMed
  8. van der Klaauw, A. A. & Farooqi, I. S. The hunger genes: pathways to obesity. Cell 161, 119–132 (2015). - PubMed
  9. Edwards, S. L., Beesley, J., French, J. D. & Dunning, A. M. Beyond GWASs: illuminating the dark road from association to function. Am. J. Hum. Genet. 93, 779–797 (2013). - PubMed
  10. Stratigopoulos, G. et al. Hypomorphism of Fto and Rpgrip1l causes obesity in mice. J. Clin. Invest. 126, 1897–1910 (2016). - PubMed
  11. Stratigopoulos, G., LeDuc, C. A., Cremona, M. L., Chung, W. K. & Leibel, R. L. Cut-like homeobox 1 (CUX1) regulates expression of the fat mass and obesity-associated and retinitis pigmentosa GTPase regulator–interacting protein-1-like (RPGRIP1L) genes and coordinates leptin receptor signaling. J. Biol. Chem. 286, 2155–2170 (2011). - PubMed
  12. Stratigopoulos, G. et al. Hypomorphism for RPGRIP1L, a ciliary gene vicinal to the FTO locus, causes increased adiposity in mice. Cell Metab. 19, 767–779 (2014). - PubMed
  13. Claussnitzer, M. et al. FTO obesity variant circuitry and adipocyte browning in humans. N. Engl. J. Med. 373, 895–907 (2015). - PubMed
  14. Smemo, S. et al. Obesity-associated variants within FTO form long-range functional connections with IRX3. Nature 507, 371–375 (2014). - PubMed
  15. Marouli, E. et al. Rare and low-frequency coding variants alter human adult height. Nature 542, 186–190 (2017). - PubMed
  16. Fuchsberger, C. et al. The genetic architecture of type 2 diabetes. Nature 536, 41–47 (2016). - PubMed
  17. Sina, M. et al. Phenotypes in three pedigrees with autosomal dominant obesity caused by haploinsufficiency mutations in the melanocortin-4 receptor gene. Am. J. Hum. Genet. 65, 1501–1507 (1999). - PubMed
  18. Pearce, L. R. et al. KSR2 mutations are associated with obesity, insulin resistance, and impaired cellular fuel oxidation. Cell 155, 765–777 (2013). - PubMed
  19. Hinney, A. et al. Several mutations in the melanocortin-4 receptor gene including a nonsense and a frameshift mutation associated with dominantly inherited obesity in humans. J. Clin. Endocrinol. Metab. 84, 1483–1486 (1999). - PubMed
  20. Purcell, S. M. et al. A polygenic burden of rare disruptive mutations in schizophrenia. Nature 506, 185–190 (2014). - PubMed
  21. van den Berg, L. et al. Melanocortin-4 receptor gene mutations in a Dutch cohort of obese children. Obesity 19, 604–611 (2011). - PubMed
  22. Surendran, P. et al. Trans-ancestry meta-analyses identify rare and common variants associated with blood pressure and hypertension. Nat. Genet. 48, 1151–1161 (2016). - PubMed
  23. Lunetta, K. L. et al. Rare coding variants and X-linked loci associated with age at menarche. Nat. Commun. 6, 7756 (2015). - PubMed
  24. Zhou, Z. et al. Cidea-deficient mice have lean phenotype and are resistant to obesity. Nat. Genet. 35, 49–56 (2003). - PubMed
  25. Tews, D. et al. Comparative gene array analysis of progenitor cells from human paired deep neck and subcutaneous adipose tissue. Mol. Cell. Endocrinol. 395, 41–50 (2014). - PubMed
  26. Stutzmann, F. et al. Non-synonymous polymorphisms in melanocortin-4 receptor protect against obesity: the two facets of a Janus obesity gene. Hum. Mol. Genet. 16, 1837–1844 (2007). - PubMed
  27. Lin, H. Q., Wang, Y., Chan, K. L., Ip, T. M. & Wan, C. C. Differential regulation of lipid metabolism genes in the brain of acetylcholinesterase knockout mice. J. Mol. Neurosci. 53, 397–408 (2014). - PubMed
  28. Vignaud, A. et al. Genetic ablation of acetylcholinesterase alters muscle function in mice. Chem. Biol. Interact. 175, 129–130 (2008). - PubMed
  29. Ji, Z., Mei, F. C. & Cheng, X. Epac, not PKA catalytic subunit, is required for 3T3-L1 preadipocyte differentiation. Front. Biosci. 2, 392–398 (2010). - PubMed
  30. Yan, J. et al. Enhanced leptin sensitivity, reduced adiposity, and improved glucose homeostasis in mice lacking exchange protein directly activated by cyclic AMP isoform 1. Mol. Cell. Biol. 33, 918–926 (2013). - PubMed
  31. Almahariq, M., Mei, F. C. & Cheng, X. Cyclic AMP sensor EPAC proteins and energy homeostasis. Trends Endocrinol. Metab. 25, 60–71 (2014). - PubMed
  32. Kai, A. K. et al. Exchange protein activated by cAMP 1 (Epac1)-deficient mice develop β-cell dysfunction and metabolic syndrome. FASEB J. 27, 4122–4135 (2013). - PubMed
  33. Hardie, D. G., Ross, F. A. & Hawley, S. A. AMPK: a nutrient and energy sensor that maintains energy homeostasis. Nat. Rev. Mol. Cell Biol. 13, 251–262 (2012). - PubMed
  34. Hardie, D. G. & Ashford, M. L. AMPK: regulating energy balance at the cellular and whole body levels. Physiology 29, 99–107 (2014). - PubMed
  35. López, M., Nogueiras, R., Tena-Sempere, M. & Diéguez, C. Hypothalamic AMPK: a canonical regulator of whole-body energy balance. Nat. Rev. Endocrinol. 12, 421–432 (2016). - PubMed
  36. Minokoshi, Y. et al. AMP-kinase regulates food intake by responding to hormonal and nutrient signals in the hypothalamus. Nature 428, 569–574 (2004). - PubMed
  37. Viollet, B. et al. The AMP-activated protein kinase α2 catalytic subunit controls whole-body insulin sensitivity. J. Clin. Invest. 111, 91–98 (2003). - PubMed
  38. Xue, B. et al. Neuronal protein tyrosine phosphatase 1B deficiency results in inhibition of hypothalamic AMPK and isoform-specific activation of AMPK in peripheral tissues. Mol. Cell. Biol. 29, 4563–4573 (2009). - PubMed
  39. Warren, H. R. et al. Genome-wide association analysis identifies novel blood pressure loci and offers biological insights into cardiovascular risk. Nat. Genet. 49, 403–415 (2017). - PubMed
  40. Chami, N. et al. Exome genotyping identifies pleiotropic variants associated with red blood cell traits. Am. J. Hum. Genet. 99, 8–21 (2016). - PubMed
  41. Li, M. et al. SOS2 and ACP1 loci identified through large-scale exome chip analysis regulate kidney development and function. J. Am. Soc. Nephrol. 28, 981–994 (2017). - PubMed
  42. Liu, C. et al. Meta-analysis identifies common and rare variants influencing blood pressure and overlapping with metabolic trait loci. Nat. Genet. 48, 1162–1170 (2016). - PubMed
  43. Schwartz, M. W., Woods, S. C., Porte, D. Jr, Seeley, R. J. & Baskin, D. G. Central nervous system control of food intake. Nature 404, 661–671 (2000). - PubMed
  44. Garfield, A. S. et al. A neural basis for melanocortin-4 receptor–regulated appetite. Nat. Neurosci. 18, 863–871 (2015). - PubMed
  45. Huszar, D. et al. Targeted disruption of the melanocortin-4 receptor results in obesity in mice. Cell 88, 131–141 (1997). - PubMed
  46. Fan, W., Boston, B. A., Kesterson, R. A., Hruby, V. J. & Cone, R. D. Role of melanocortinergic neurons in feeding and the agouti obesity syndrome. Nature 385, 165–168 (1997). - PubMed
  47. Yeo, G. S. H. et al. A frameshift mutation in MC4R associated with dominantly inherited human obesity. Nat. Genet. 20, 111–112 (1998). - PubMed
  48. Vaisse, C., Clement, K., Guy-Grand, B. & Froguel, P. A frameshift mutation in human MC4R is associated with a dominant form of obesity. Nat. Genet. 20, 113–114 (1998). - PubMed
  49. Lubrano-Berthelier, C. et al. Melanocortin 4 receptor mutations in a large cohort of severely obese adults: prevalence, functional classification, genotype–phenotype relationship, and lack of association with binge eating. J. Clin. Endocrinol. Metab. 91, 1811–1818 (2006). - PubMed
  50. Farooqi, I. S. et al. Clinical spectrum of obesity and mutations in the melanocortin 4 receptor gene. N. Engl. J. Med. 348, 1085–1095 (2003). - PubMed
  51. Lek, M. et al. Analysis of protein-coding genetic variation in 60,706 humans. Nature 536, 285–291 (2016). - PubMed
  52. Hinney, A. et al. Melanocortin-4 receptor gene: case–control study and transmission disequilibrium test confirm that functionally relevant mutations are compatible with a major gene effect for extreme obesity. J. Clin. Endocrinol. Metab. 88, 4258–4267 (2003). - PubMed
  53. Speliotes, E. K. et al. Association analyses of 249,796 individuals reveal 18 new loci associated with body mass index. Nat. Genet. 42, 937–948 (2010). - PubMed
  54. Saxena, R. et al. Genetic variation in GIPR influences the glucose and insulin responses to an oral glucose challenge. Nat. Genet. 42, 142–148 (2010). - PubMed
  55. Miyawaki, K. et al. Inhibition of gastric inhibitory polypeptide signaling prevents obesity. Nat. Med. 8, 738–742 (2002). - PubMed
  56. Hansotia, T. et al. Extrapancreatic incretin receptors modulate glucose homeostasis, body weight, and energy expenditure. J. Clin. Invest. 117, 143–152 (2007). - PubMed
  57. Fulurija, A. et al. Vaccination against GIP for the treatment of obesity. PLoS One 3, e3163 (2008). - PubMed
  58. Finan, B. et al. Reappraisal of GIP pharmacology for metabolic diseases. Trends Mol. Med. 22, 359–376 (2016). - PubMed
  59. Irwin, N. & Flatt, P. R. Evidence for beneficial effects of compromised gastric inhibitory polypeptide action in obesity-related diabetes and possible therapeutic implications. Diabetologia 52, 1724–1731 (2009). - PubMed
  60. Revelli, J. P. et al. Profound obesity secondary to hyperphagia in mice lacking kinase suppressor of ras 2. Obesity 19, 1010–1018 (2011). - PubMed
  61. Costanzo-Garvey, D. L. et al. KSR2 is an essential regulator of AMP kinase, energy expenditure, and insulin sensitivity. Cell Metab. 10, 366–378 (2009). - PubMed
  62. Brommage, R. et al. High-throughput screening of mouse knockout lines identifies true lean and obese phenotypes. Obesity 16, 2362–2367 (2008). - PubMed
  63. Liu, L. et al. Proteomic characterization of the dynamic KSR-2 interactome, a signaling scaffold complex in MAPK pathway. Biochim. Biophys. Acta 1794, 1485–1495 (2009). - PubMed
  64. Kühnen, P. et al. Proopiomelanocortin deficiency treated with a melanocortin-4 receptor agonist. N. Engl. J. Med. 375, 240–246 (2016). - PubMed
  65. Xiang, Y. Y., Dong, H., Yang, B. B., Macdonald, J. F. & Lu, W. Y. Interaction of acetylcholinesterase with neurexin-1β regulates glutamatergic synaptic stability in hippocampal neurons. Mol. Brain 7, 15 (2014). - PubMed
  66. Bartels, C. F., Zelinski, T. & Lockridge, O. Mutation at codon 322 in the human acetylcholinesterase (ACHE) gene accounts for YT blood group polymorphism. Am. J. Hum. Genet. 52, 928–936 (1993). - PubMed
  67. Farlow, M. R. et al. Effectiveness and tolerability of high-dose (23 mg/d) versus standard-dose (10 mg/d) donepezil in moderate to severe Alzheimer’s disease: a 24-week, randomized, double-blind study. Clin. Ther. 32, 1234–1251 (2010). - PubMed
  68. Farlow, M. et al. Safety and tolerability of donepezil 23 mg in moderate to severe Alzheimer’s disease. BMC Neurol. 11, 57 (2011). - PubMed
  69. Tariot, P., Salloway, S., Yardley, J., Mackell, J. & Moline, M. Long-term safety and tolerability of donepezil 23 mg in patients with moderate to severe Alzheimer’s disease. BMC Res. Notes 5, 283 (2012). - PubMed
  70. Hu, Y. et al. Role of exchange protein directly activated by cyclic AMP isoform 1 in energy homeostasis: regulation of leptin expression and secretion in white adipose tissue. Mol. Cell. Biol. 36, 2440–2450 (2016). - PubMed
  71. Altarejos, J. Y. et al. The Creb1 coactivator Crtc1 is required for energy balance and fertility. Nat. Med. 14, 1112–1117 (2008). - PubMed
  72. Winnier, D. A. et al. Transcriptomic identification of ADH1B as a novel candidate gene for obesity and insulin resistance in human adipose tissue in Mexican Americans from the Veterans Administration Genetic Epidemiology Study (VAGES). PLoS One 10, e0119941 (2015). - PubMed
  73. Molotkov, A., Deltour, L., Foglio, M. H., Cuenca, A. E. & Duester, G. Distinct retinoid metabolic functions for alcohol dehydrogenase genes Adh1 and Adh4 in protection against vitamin A toxicity or deficiency revealed in double null mutant mice. J. Biol. Chem. 277, 13804–13811 (2002). - PubMed
  74. GTEx Consortium. The Genotype-Tissue Expression (GTEx) pilot analysis: multitissue gene regulation in humans. Science 348, 648–660 (2015). - PubMed
  75. Volpicelli-Daley, L. A., Duysen, E. G., Lockridge, O. & Levey, A. I. Altered hippocampal muscarinic receptors in acetylcholinesterase-deficient mice. Ann. Neurol. 53, 788–796 (2003). - PubMed
  76. Ivanenkov, V. V., Murphy-Piedmonte, D. M. & Kirley, T. L. Bacterial expression, characterization, and disulfide bond determination of soluble human NTPDase6 (CD39L2) nucleotidase: implications for structure and function. Biochemistry 42, 11726–11735 (2003). - PubMed
  77. Jain, R. N. et al. Hip1r is expressed in gastric parietal cells and is required for tubulovesicle formation and cell survival in mice. J. Clin. Invest. 118, 2459–2470 (2008). - PubMed
  78. Engqvist-Goldstein, A. E. et al. RNAi-mediated Hip1R silencing results in stable association between the endocytic machinery and the actin assembly machinery. Mol. Biol. Cell 15, 1666–1679 (2004). - PubMed
  79. Tao, Y. X. The melanocortin-4 receptor: physiology, pharmacology, and pathophysiology. Endocr. Rev. 31, 506–543 (2010). - PubMed
  80. Stutzmann, F. et al. Prevalence of melanocortin-4 receptor deficiency in Europeans and their age-dependent penetrance in multigenerational pedigrees. Diabetes 57, 2511–2518 (2008). - PubMed
  81. Vaisse, C. et al. Melanocortin-4 receptor mutations are a frequent and heterogeneous cause of morbid obesity. J. Clin. Invest. 106, 253–262 (2000). - PubMed
  82. Schönke, M., Myers, M. G. Jr., Zierath, J. R. & Björnholm, M. Skeletal muscle AMP-activated protein kinase γ1 - PubMed
  83. Pellinen, T. et al. Small GTPase Rab21 regulates cell adhesion and controls endosomal traffic of β1-integrins. J. Cell Biol. 173, 767–780 (2006). - PubMed
  84. Banerjee, U. & Cheng, X. Exchange protein directly activated by cAMP encoded by the mammalian rapgef3 gene: structure, function and therapeutics. Gene 570, 157–167 (2015). - PubMed
  85. Rippey, C. et al. Formation of chimeric genes by copy-number variation as a mutational mechanism in schizophrenia. Am. J. Hum. Genet. 93, 697–710 (2013). - PubMed
  86. Schmitz, C., Kinge, P. & Hutter, H. Axon guidance genes identified in a large-scale RNAi screen using the RNAi-hypersensitive Caenorhabditis elegans strain nre-1(hd20) lin-15b(hd126). Proc. Natl. Acad. Sci. USA 104, 834–839 (2007). - PubMed
  87. Setoguchi, R. et al. Repression of the transcription factor Th-POK by Runx complexes in cytotoxic T cell development. Science 319, 822–825 (2008). - PubMed
  88. Widom, R. L., Culic, I., Lee, J. Y. & Korn, J. H. Cloning and characterization of hcKrox, a transcriptional regulator of extracellular matrix gene expression. Gene 198, 407–420 (1997). - PubMed
  89. Sun, X. et al. Deletion of Atbf1/Zfhx3 in mouse prostate causes neoplastic lesions, likely by attenuation of membrane and secretory proteins and multiple signaling pathways. Neoplasia 16, 377–389 (2014). - PubMed
  90. Parsons, M. J. et al. The regulatory factor ZFHX3 modifies circadian function in SCN via an AT motif–driven axis. Cell 162, 607–621 (2015). - PubMed
  91. Balzani, E. et al. The Zfhx3-mediated axis regulates sleep and interval timing in mice. Cell Rep. 16, 615–621 (2016). - PubMed
  92. Kao, Y. H. et al. ZFHX3 knockdown increases arrhythmogenesis and dysregulates calcium homeostasis in HL-1 atrial myocytes. Int. J. Cardiol. 210, 85–92 (2016). - PubMed
  93. Auer, P. L., Reiner, A. P. & Leal, S. M. The effect of phenotypic outliers and non-normality on rare-variant association testing. Eur. J. Hum. Genet. 24, 1188–1194 (2016). - PubMed
  94. Goldstein, J. I. et al. zCall: a rare variant caller for array-based genotyping: genetics and population analysis. Bioinformatics 28, 2543–2545 (2012). - PubMed
  95. Grove, M. L. et al. Best practices and joint calling of the HumanExome BeadChip: the CHARGE Consortium. PLoS One 8, e68095 (2013). - PubMed
  96. Zhan, X., Hu, Y., Li, B., Abecasis, G. R. & Liu, D. J. RVTESTS: an efficient and comprehensive tool for rare variant association analysis using sequence data. Bioinformatics 32, 1423–1426 (2016). - PubMed
  97. Liu, D. J. et al. Meta-analysis of gene-level tests for rare variant association. Nat. Genet. 46, 200–204 (2014). - PubMed
  98. Winkler, T. W. et al. Quality control and conduct of genome-wide association meta-analyses. Nat. Protoc. 9, 1192–1212 (2014). - PubMed
  99. Winkler, T. W. et al. EasyStrata: evaluation and visualization of stratified genome-wide association meta-analysis data. Bioinformatics 31, 259–261 (2015). - PubMed
  100. Wu, M. C. et al. Rare-variant association testing for sequencing data with the sequence kernel association test. Am. J. Hum. Genet. 89, 82–93 (2011). - PubMed
  101. Price, A. L. et al. Pooled association tests for rare variants in exon-resequencing studies. Am. J. Hum. Genet. 86, 832–838 (2010). - PubMed
  102. Kiezun, A. et al. Exome sequencing and the genetic basis of complex traits. Nat. Genet. 44, 623–630 (2012). - PubMed
  103. Feng, S., Liu, D., Zhan, X., Wing, M. K. & Abecasis, G. R. RAREMETAL: fast and powerful meta-analysis for rare variants. Bioinformatics 30, 2828–2829 (2014). - PubMed
  104. Yang, J. et al. Genomic inflation factors under polygenic inheritance. Eur. J. Hum. Genet. 19, 807–812 (2011). - PubMed
  105. Willer, C. J., Li, Y. & Abecasis, G. R. METAL: fast and efficient meta-analysis of genomewide association scans. Bioinformatics 26, 2190–2191 (2010). - PubMed
  106. Thorleifsson, G. et al. Genome-wide association yields new sequence variants at seven loci that associate with measures of obesity. Nat. Genet. 41, 18–24 (2009). - PubMed
  107. Denny, J. C. et al. PheWAS: demonstrating the feasibility of a phenome-wide scan to discover gene–disease associations. Bioinformatics 26, 1205–1210 (2010). - PubMed
  108. Pers, T. H. et al. Biological interpretation of genome-wide association studies using predicted gene functions. Nat. Commun. 6, 5890 (2015). - PubMed

Substances

MeSH terms

Publication Types

Grant support